These data indicated that miR-301 inhibition or PTEN overexpression repressed tumor growth and angiogenesis in ESCC, while miR-301 elevation or PTEN silencing had reverse effects. The gene discussed is PTEN; the disease is esophageal squamous cell carcinoma.